Latest News
'25 at 25': Reducing deaths among people starting HIV treatment with advanced disease
In this part of our ‘25 at 25’ series, we look back at the REALITY trial, which found a way to prevent deaths among people starting HIV treatment with advanced disease.
'25 at 25': Defining treatment for ovarian cancer
In this article in our series celebrating 25 years of smarter studies, global impact and better health, we look at how the MRC CTU at UCL has helped define treatment for ovarian cancer.
Our methodology research at ICTMC 2024
MRC CTU at UCL methodology researchers will have a large turnout at the 7th International Clinical Trials Methodology Conference in Edinburgh, UK.
New podcast episode: Preventing multidrug-resistant tuberculosis
In this episode of the Trial Talk podcast, we find out more about the TB-CHAMP and VQUIN trials, and how the teams came together to combine their data and strengthen their evidence.
No clear evidence that adding diabetes drug to standard prostate cancer treatment reduces risk of death, but side effects of hormone therapy lessened
New results from the STAMPEDE trial metformin comparison were presented at the 2024 ESMO Congress.